TECH EXPERT
Dr Dimitri Dimitriou

Dr Dimitri Dimitriou

Managing Director

DyoDelta Biosciences Ltd

EXPERTISE:
Healthcare - Product Design & Development, Test & Verification/Clinical Trials
Life Sciences - Product Design & Development, Test & Verification/Clinical Trials
Show more >
LOCATION:
United Kingdom

BIOGRAPHY

Dr Dimitri Dimitriou is currently CEO of ImmuPharma PLC, a biotech company listed on the London Stock Exchange and Euronext in Brussels, developing novel medicines in collaboration with the French National Research Institution. He is also Founder and Managing Director of DyoDelta Biosciences Ltd, a company that specialises in developing and commercialising natural products for health, and providing corporate advisory and business development services in pharma and biotech to support companies in product licensing, valuation, due diligence, new market launch, etc.

Dimitri has over 30 years of experience in pharmaceuticals. Passionate about medical innovation, Dimitri is advisor to numerous companies since 2001. His diverse areas of expertise in both technical and business domains include European Commission Registered Scientific Expert; Drug discovery and development; LSE and Euronext regulations; Corporate strategy, board management and business development; Licensing transactions and M&A; Venture investments, corporate finance, capital raising and public listings; Corporate governance, public and investor relations.

PORTFOLIO

Drug Development, Pharmaceuticals
  • Involved in drug development for autoimmune diseases, systemic lupus erythematosus, multiple sclerosis, Parkinson's disease, Alzheimer's disease, chronic inflammatory demyelinating polyneuropathy, cancer, oral mucositis, bacterial and viral infections, thrombosis, diabetes, NASH, obesity, osteoporosis, IBS/IBD, Sjogren's syndrome, and rheumatoid arthritis
  • As co-founder and CEO of Polytherics, a spin-off from Imperial Collage and The School of Pharmacy of the University of London, helped devise product development strategy
  • As commercial advisor of Unibioscreen, an oncology start-up in Belgium, provided input in the early development of the drugs
  • As CEO of ImmuPharma, assisted in the product development of novel pharmaceuticals, from pre-clinical to end of Phase 3
  • Supported numerous companies in the due diligence, scientific and commercial evaluation of products

Expertise Provided
  • Healthcare - Product Design & Development, Prototype Build, Test & Verification/Clinical Trials, Certification/Regulatory Compliance
  • Life Sciences - Product Design & Development, Prototype Build, Test & Verification/Clinical Trials, Certification/Regulatory Compliance
Testing and Verification

As co-founder and Chairman of a Swiss MedTech company, guided the testing and verification of 5 products, from concept to final product.


Expertise Provided
  • Healthcare - Test & Verification/Clinical Trials, Certification/Regulatory Compliance
  • Life Sciences - Test & Verification/Clinical Trials, Certification/Regulatory Compliance
RELATED TECH EXPERT
LingLing Sun

Electronics
Healthcare

Dr Susmita Bandyopadhyay

Chemicals
Healthcare

Dr Gu Keyu

Life Sciences

Dr Ritu Bhalla

Life Sciences

Dr Sun Guang Wen

Life Sciences

Dr Suchitra Derebail

Healthcare
Life Sciences

Dr Gan Eng Seng

Life Sciences

Dr Sharon Lim

Healthcare
Life Sciences

Dr Chiradip Chatterjee

Chemicals
Personal Care

Dr Harmeet Singh

Healthcare
Life Sciences